Classification ![]() |
|
Compound class | Antibody |
Approved drug? | Yes (FDA (2015)) |
International Nonproprietary Names ![]() |
|
INN number | INN |
9083 | necitumumab |
Synonyms ![]() |
11F8 | IMC-11F8 | LY3012211 | Portrazza® |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 294 |
Other databases | |
GtoPdb PubChem SID | 249565770 |
Search PubMed clinical trials | necitumumab |
Search PubMed titles | necitumumab |
Search PubMed titles/abstracts | necitumumab |
Wikipedia | Necitumumab |
Comments |
Necitumumab is a monoclonal antibody with clinical antineoplastic action [1-3]. Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. |